CIDRAP: Lawmakers want answers on CDC-funded hepatitis B vaccine trial in Africa

Back to the "HIV and Co-Infections News" list

CIDRAP news story

US lawmakers have sent a letter to federal health officials demanding answers on how and why a controversial vaccine trial in West Africa received federal funding.

The letter from Democratic members of the House Energy & Commerce Committee to Centers for Disease Control and Prevention (CDC) Acting Director Jim O’Neill asks for all documentation regarding the decision to award a five-year, $1.6 million grant to a team of Danish researchers conducting the study, which aims to assess the overall health impact of the hepatitis B vaccine birth dose in Guinea-Bissau. Half of the estimated 14,000 newborns enrolled in the randomized controlled trial will not receive the birth dose of the vaccine.

Read the full news story here.

 

Source : CIDRAP

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.